ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psoriatic Arthritis Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-22M11989
Home | Market Reports | Health| Pharmacy
Global Psoriatic Arthritis Drugs Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Psoriatic Arthritis Drugs Market Research Report 2025

Code: QYRE-Auto-22M11989
Report
August 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Janssen
Amgen Inc
Pfizer Inc
Eli Lilly
Celgene

Psoriatic Arthritis Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Psoriatic Arthritis Drugs Market

Psoriatic Arthritis Drugs Market

The global market for Psoriatic Arthritis Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Drugs.
The Psoriatic Arthritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriatic Arthritis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriatic Arthritis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Psoriatic Arthritis Drugs Market Report

Report Metric Details
Report Name Psoriatic Arthritis Drugs Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbvie, Janssen, Amgen, Pfizer, Eli-Lilly, Celgene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Psoriatic Arthritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Psoriatic Arthritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Psoriatic Arthritis Drugs Market report?

Ans: The main players in the Psoriatic Arthritis Drugs Market are Abbvie, Janssen, Amgen, Pfizer, Eli-Lilly, Celgene

What are the Application segmentation covered in the Psoriatic Arthritis Drugs Market report?

Ans: The Applications covered in the Psoriatic Arthritis Drugs Market report are Mild Psoriatic Arthritis, Moderate Psoriatic Arthritis, Severe Psoriatic Arthritis

What are the Type segmentation covered in the Psoriatic Arthritis Drugs Market report?

Ans: The Types covered in the Psoriatic Arthritis Drugs Market report are TNF Inhibitors, PDE4 Inhibitors, Interleukin Blockers, Other

Recommended Reports

Autoimmune & Inflammatory

Cancer & Oncology

Pharmaceutical Market Trends

1 Psoriatic Arthritis Drugs Market Overview
1.1 Product Definition
1.2 Psoriatic Arthritis Drugs by Type
1.2.1 Global Psoriatic Arthritis Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Other
1.3 Psoriatic Arthritis Drugs by Application
1.3.1 Global Psoriatic Arthritis Drugs Market Value by Application (2024 VS 2031)
1.3.2 Mild Psoriatic Arthritis
1.3.3 Moderate Psoriatic Arthritis
1.3.4 Severe Psoriatic Arthritis
1.4 Global Psoriatic Arthritis Drugs Market Size Estimates and Forecasts
1.4.1 Global Psoriatic Arthritis Drugs Revenue 2020-2031
1.4.2 Global Psoriatic Arthritis Drugs Sales 2020-2031
1.4.3 Global Psoriatic Arthritis Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Psoriatic Arthritis Drugs Market Competition by Manufacturers
2.1 Global Psoriatic Arthritis Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Psoriatic Arthritis Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Psoriatic Arthritis Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Psoriatic Arthritis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Psoriatic Arthritis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Psoriatic Arthritis Drugs, Product Type & Application
2.7 Global Key Manufacturers of Psoriatic Arthritis Drugs, Date of Enter into This Industry
2.8 Global Psoriatic Arthritis Drugs Market Competitive Situation and Trends
2.8.1 Global Psoriatic Arthritis Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Psoriatic Arthritis Drugs Players Market Share by Revenue
2.8.3 Global Psoriatic Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Psoriatic Arthritis Drugs Market Scenario by Region
3.1 Global Psoriatic Arthritis Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Psoriatic Arthritis Drugs Sales by Region: 2020-2031
3.2.1 Global Psoriatic Arthritis Drugs Sales by Region: 2020-2025
3.2.2 Global Psoriatic Arthritis Drugs Sales by Region: 2026-2031
3.3 Global Psoriatic Arthritis Drugs Revenue by Region: 2020-2031
3.3.1 Global Psoriatic Arthritis Drugs Revenue by Region: 2020-2025
3.3.2 Global Psoriatic Arthritis Drugs Revenue by Region: 2026-2031
3.4 North America Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.4.1 North America Psoriatic Arthritis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Psoriatic Arthritis Drugs Sales by Country (2020-2031)
3.4.3 North America Psoriatic Arthritis Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.5.1 Europe Psoriatic Arthritis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Psoriatic Arthritis Drugs Sales by Country (2020-2031)
3.5.3 Europe Psoriatic Arthritis Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psoriatic Arthritis Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Psoriatic Arthritis Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Psoriatic Arthritis Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Psoriatic Arthritis Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.7.1 Latin America Psoriatic Arthritis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Psoriatic Arthritis Drugs Sales by Country (2020-2031)
3.7.3 Latin America Psoriatic Arthritis Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Psoriatic Arthritis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Psoriatic Arthritis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Psoriatic Arthritis Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Psoriatic Arthritis Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Psoriatic Arthritis Drugs Sales by Type (2020-2031)
4.1.1 Global Psoriatic Arthritis Drugs Sales by Type (2020-2025)
4.1.2 Global Psoriatic Arthritis Drugs Sales by Type (2026-2031)
4.1.3 Global Psoriatic Arthritis Drugs Sales Market Share by Type (2020-2031)
4.2 Global Psoriatic Arthritis Drugs Revenue by Type (2020-2031)
4.2.1 Global Psoriatic Arthritis Drugs Revenue by Type (2020-2025)
4.2.2 Global Psoriatic Arthritis Drugs Revenue by Type (2026-2031)
4.2.3 Global Psoriatic Arthritis Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Psoriatic Arthritis Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Psoriatic Arthritis Drugs Sales by Application (2020-2031)
5.1.1 Global Psoriatic Arthritis Drugs Sales by Application (2020-2025)
5.1.2 Global Psoriatic Arthritis Drugs Sales by Application (2026-2031)
5.1.3 Global Psoriatic Arthritis Drugs Sales Market Share by Application (2020-2031)
5.2 Global Psoriatic Arthritis Drugs Revenue by Application (2020-2031)
5.2.1 Global Psoriatic Arthritis Drugs Revenue by Application (2020-2025)
5.2.2 Global Psoriatic Arthritis Drugs Revenue by Application (2026-2031)
5.2.3 Global Psoriatic Arthritis Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Psoriatic Arthritis Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbvie
6.1.1 Abbvie Company Information
6.1.2 Abbvie Description and Business Overview
6.1.3 Abbvie Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbvie Psoriatic Arthritis Drugs Product Portfolio
6.1.5 Abbvie Recent Developments/Updates
6.2 Janssen
6.2.1 Janssen Company Information
6.2.2 Janssen Description and Business Overview
6.2.3 Janssen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Janssen Psoriatic Arthritis Drugs Product Portfolio
6.2.5 Janssen Recent Developments/Updates
6.3 Amgen
6.3.1 Amgen Company Information
6.3.2 Amgen Description and Business Overview
6.3.3 Amgen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Amgen Psoriatic Arthritis Drugs Product Portfolio
6.3.5 Amgen Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Psoriatic Arthritis Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Eli-Lilly
6.5.1 Eli-Lilly Company Information
6.5.2 Eli-Lilly Description and Business Overview
6.5.3 Eli-Lilly Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli-Lilly Psoriatic Arthritis Drugs Product Portfolio
6.5.5 Eli-Lilly Recent Developments/Updates
6.6 Celgene
6.6.1 Celgene Company Information
6.6.2 Celgene Description and Business Overview
6.6.3 Celgene Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Celgene Psoriatic Arthritis Drugs Product Portfolio
6.6.5 Celgene Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psoriatic Arthritis Drugs Industry Chain Analysis
7.2 Psoriatic Arthritis Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psoriatic Arthritis Drugs Production Mode & Process Analysis
7.4 Psoriatic Arthritis Drugs Sales and Marketing
7.4.1 Psoriatic Arthritis Drugs Sales Channels
7.4.2 Psoriatic Arthritis Drugs Distributors
7.5 Psoriatic Arthritis Drugs Customer Analysis
8 Psoriatic Arthritis Drugs Market Dynamics
8.1 Psoriatic Arthritis Drugs Industry Trends
8.2 Psoriatic Arthritis Drugs Market Drivers
8.3 Psoriatic Arthritis Drugs Market Challenges
8.4 Psoriatic Arthritis Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Janssen
Amgen Inc
Pfizer Inc
Eli Lilly
Celgene
List of Tables
 Table 1. Global Psoriatic Arthritis Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Psoriatic Arthritis Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Psoriatic Arthritis Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Psoriatic Arthritis Drugs Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Psoriatic Arthritis Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Psoriatic Arthritis Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Psoriatic Arthritis Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Psoriatic Arthritis Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Psoriatic Arthritis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Psoriatic Arthritis Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Psoriatic Arthritis Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Psoriatic Arthritis Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Psoriatic Arthritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Psoriatic Arthritis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Psoriatic Arthritis Drugs Sales by Region (2020-2025) & (K MT)
 Table 18. Global Psoriatic Arthritis Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Psoriatic Arthritis Drugs Sales by Region (2026-2031) & (K MT)
 Table 20. Global Psoriatic Arthritis Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Psoriatic Arthritis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Psoriatic Arthritis Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Psoriatic Arthritis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Psoriatic Arthritis Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Psoriatic Arthritis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Psoriatic Arthritis Drugs Sales by Country (2020-2025) & (K MT)
 Table 27. North America Psoriatic Arthritis Drugs Sales by Country (2026-2031) & (K MT)
 Table 28. North America Psoriatic Arthritis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Psoriatic Arthritis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Psoriatic Arthritis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Psoriatic Arthritis Drugs Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Psoriatic Arthritis Drugs Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Psoriatic Arthritis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Psoriatic Arthritis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Psoriatic Arthritis Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Psoriatic Arthritis Drugs Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Psoriatic Arthritis Drugs Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Psoriatic Arthritis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Psoriatic Arthritis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Psoriatic Arthritis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Psoriatic Arthritis Drugs Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Psoriatic Arthritis Drugs Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Psoriatic Arthritis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Psoriatic Arthritis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Psoriatic Arthritis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Psoriatic Arthritis Drugs Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Psoriatic Arthritis Drugs Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Psoriatic Arthritis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Psoriatic Arthritis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Psoriatic Arthritis Drugs Sales (K MT) by Type (2020-2025)
 Table 51. Global Psoriatic Arthritis Drugs Sales (K MT) by Type (2026-2031)
 Table 52. Global Psoriatic Arthritis Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Psoriatic Arthritis Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Psoriatic Arthritis Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Psoriatic Arthritis Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Psoriatic Arthritis Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Psoriatic Arthritis Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Psoriatic Arthritis Drugs Price (USD/MT) by Type (2020-2025)
 Table 59. Global Psoriatic Arthritis Drugs Price (USD/MT) by Type (2026-2031)
 Table 60. Global Psoriatic Arthritis Drugs Sales (K MT) by Application (2020-2025)
 Table 61. Global Psoriatic Arthritis Drugs Sales (K MT) by Application (2026-2031)
 Table 62. Global Psoriatic Arthritis Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Psoriatic Arthritis Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Psoriatic Arthritis Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Psoriatic Arthritis Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Psoriatic Arthritis Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Psoriatic Arthritis Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Psoriatic Arthritis Drugs Price (USD/MT) by Application (2020-2025)
 Table 69. Global Psoriatic Arthritis Drugs Price (USD/MT) by Application (2026-2031)
 Table 70. Abbvie Company Information
 Table 71. Abbvie Description and Business Overview
 Table 72. Abbvie Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Abbvie Psoriatic Arthritis Drugs Product
 Table 74. Abbvie Recent Developments/Updates
 Table 75. Janssen Company Information
 Table 76. Janssen Description and Business Overview
 Table 77. Janssen Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Janssen Psoriatic Arthritis Drugs Product
 Table 79. Janssen Recent Developments/Updates
 Table 80. Amgen Company Information
 Table 81. Amgen Description and Business Overview
 Table 82. Amgen Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Amgen Psoriatic Arthritis Drugs Product
 Table 84. Amgen Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Pfizer Psoriatic Arthritis Drugs Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Eli-Lilly Company Information
 Table 91. Eli-Lilly Description and Business Overview
 Table 92. Eli-Lilly Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Eli-Lilly Psoriatic Arthritis Drugs Product
 Table 94. Eli-Lilly Recent Developments/Updates
 Table 95. Celgene Company Information
 Table 96. Celgene Description and Business Overview
 Table 97. Celgene Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Celgene Psoriatic Arthritis Drugs Product
 Table 99. Celgene Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Psoriatic Arthritis Drugs Distributors List
 Table 103. Psoriatic Arthritis Drugs Customers List
 Table 104. Psoriatic Arthritis Drugs Market Trends
 Table 105. Psoriatic Arthritis Drugs Market Drivers
 Table 106. Psoriatic Arthritis Drugs Market Challenges
 Table 107. Psoriatic Arthritis Drugs Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Psoriatic Arthritis Drugs
 Figure 2. Global Psoriatic Arthritis Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Psoriatic Arthritis Drugs Market Share by Type: 2024 & 2031
 Figure 4. TNF Inhibitors Product Picture
 Figure 5. PDE4 Inhibitors Product Picture
 Figure 6. Interleukin Blockers Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Psoriatic Arthritis Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Psoriatic Arthritis Drugs Market Share by Application: 2024 & 2031
 Figure 10. Mild Psoriatic Arthritis
 Figure 11. Moderate Psoriatic Arthritis
 Figure 12. Severe Psoriatic Arthritis
 Figure 13. Global Psoriatic Arthritis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Psoriatic Arthritis Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Psoriatic Arthritis Drugs Sales (2020-2031) & (K MT)
 Figure 16. Global Psoriatic Arthritis Drugs Average Price (USD/MT) & (2020-2031)
 Figure 17. Psoriatic Arthritis Drugs Report Years Considered
 Figure 18. Psoriatic Arthritis Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global Psoriatic Arthritis Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Psoriatic Arthritis Drugs Players: Market Share by Revenue in Psoriatic Arthritis Drugs in 2024
 Figure 21. Psoriatic Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Psoriatic Arthritis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Psoriatic Arthritis Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America Psoriatic Arthritis Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Psoriatic Arthritis Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Psoriatic Arthritis Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Psoriatic Arthritis Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Psoriatic Arthritis Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Psoriatic Arthritis Drugs Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Psoriatic Arthritis Drugs Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Psoriatic Arthritis Drugs Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Psoriatic Arthritis Drugs Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Psoriatic Arthritis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Psoriatic Arthritis Drugs by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Psoriatic Arthritis Drugs by Type (2020-2031)
 Figure 58. Global Psoriatic Arthritis Drugs Price (USD/MT) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Psoriatic Arthritis Drugs by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Psoriatic Arthritis Drugs by Application (2020-2031)
 Figure 61. Global Psoriatic Arthritis Drugs Price (USD/MT) by Application (2020-2031)
 Figure 62. Psoriatic Arthritis Drugs Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025
Psoriasis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriasis Treatment Drugs Market Research Report 2025
Global Psoriasis Biologics Drugs Market Research Report 2025
Rheumatology Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatoid Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NSAIDs Market Research Report 2025
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Autoimmune Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriatic Arthritis Therapeutics Drug Market Insights Forecast to 2030
Global Autoimmune Diseases Treatment Market Research Report 2024
Global Immune Drugs Market Insights Forecast to 2030
Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Orthopedics Nonsteroidal Anti Inflammatory Drugs NSAIDs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions